Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Equity Ratio (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Equity Ratio for 17 consecutive years, with 0.21 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 16.14% to 0.21 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.21 through Dec 2025, up 16.14% year-over-year, with the annual reading at 0.21 for FY2025, 16.14% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.21 at Bristol Myers Squibb, up from 0.19 in the prior quarter.
  • The five-year high for Equity Ratio was 0.49 in Q3 2023, with the low at 0.41 in Q1 2023.
  • Average Equity Ratio over 5 years is 0.06, with a median of 0.0 recorded in 2024.
  • The sharpest move saw Equity Ratio crashed 2386.89% in 2022, then soared 81446.34% in 2023.
  • Over 5 years, Equity Ratio stood at 0.22 in 2021, then plummeted by 99.73% to 0.0 in 2022, then skyrocketed by 81446.34% to 0.48 in 2023, then plummeted by 63.14% to 0.18 in 2024, then grew by 16.14% to 0.21 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.21, 0.19, and 0.02 for Q4 2025, Q3 2025, and Q2 2025 respectively.